Govt Job for Ph.D, M.Pharm as Scientist at Govt of India Enterprise

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare.

HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 7 subsidiary companies, 22 regional offices and having presence in more than 115 countries, HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.

Post : SCIENTIST E3

Job Description
1. Development of drug delivery systems/ implants for regulated markets
2. Preparation of dossier for regulatory submissions for obtaining marketing clearance in regulated markets
3. Scale up and Technology Transfer
4. Meeting audit as per regulatory requirements

Candidate Profile
Maximum Age: 40 years as on 01.07.2021
Consolidated pay range (For Fixed Term Contract engagement): 35,000 –65,000/- (Senior Manager (E3) per month.

(The consolidated pay will be fixed within the pay range depending on the qualification, experience and the current pay drawn by the candidate. The consolidated pay will be inclusive of all allowances and benefits).

Educational Qualification:
Essential: PhD in Pharmaceutics/ M.Pharm Pharmaceutics

Experience
Essential: Minimum 5 years post qualification for PhD/ Minimum 8 Years post qualification experience for M.Pharm
Desirable: Patents, Technology transfers in novel drug delivery systems

General Conditions
• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.
• Canvassing in any form will be a disqualification.

Location : Anywhere in India

Last Date : 28th July, 2021

Reference Code HLL/HR/015/2021

Related Posts

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

BENGALURU: Sending a strong message against officials who have made it a habit to ignore the applications under Right to Information (RTI) Act, the Karnataka Information Commission has cracked the…

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

New Delhi: The number of drug samples declared as Not of Standard Quality (NSQ) by the drug regulators in the country has registered over two-fold growth during the 12 months of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

Karnataka State Information Commission slaps ₹1 lakh penalty on BDA official for failing to provide information

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

NSQ reporting nearly doubles in 2025, buoyed by greater state participation

Two Gyms In Firozabad Raided, Seize 20 Mephentermine Injections Amid Health Concerns

Two Gyms In Firozabad Raided, Seize 20 Mephentermine Injections Amid Health Concerns

Delhi Drugs Control Department Seizes Insulin Stock Worth Rs 20.06 Lakh

Delhi Drugs Control Department Seizes Insulin Stock Worth Rs 20.06 Lakh

Kerala Health Department Has Launched The MeHEALTH App

Kerala Health Department Has Launched The MeHEALTH App

War Could Affect Up To ₹5,000 Crore Of Pharma Exports And Disrupt Supply Chains

War Could Affect Up To ₹5,000 Crore Of Pharma Exports And Disrupt Supply Chains